HCG18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.732600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.911200E-01
Normal-vs-Stage2
3.967600E-01
Normal-vs-Stage3
1.664820E-01
Normal-vs-Stage4
5.614200E-01
Stage1-vs-Stage2
7.494800E-01
Stage1-vs-Stage3
9.168400E-02
Stage1-vs-Stage4
1.234650E-01
Stage2-vs-Stage3
1.808230E-01
Stage2-vs-Stage4
4.301900E-02
Stage3-vs-Stage4
2.354000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.939400E-01
Normal-vs-AfricanAmerican
4.701800E-01
Normal-vs-Asian
4.290800E-01
Caucasian-vs-AfricanAmerican
9.438000E-01
Caucasian-vs-Asian
6.954600E-01
AfricanAmerican-vs-Asian
8.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.443000E-01
Normal-vs-Female
5.437800E-01
Male-vs-Female
3.636600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.820600E-01
Normal-vs-Age(41-60Yrs)
5.424600E-01
Normal-vs-Age(61-80Yrs)
4.759600E-01
Normal-vs-Age(81-100Yrs)
4.851800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.126200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.119200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.145600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.470200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.714600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.782200E-01
Normal-vs-Daily Drinker
7.586200E-02
Normal-vs-Weekly Drinker
8.211400E-01
Normal-vs-Occasional Drinker
5.028800E-01
Normal-vs-Social Drinker
8.916200E-01
Non Drinker-vs-Daily Drinker
5.762100E-02
Non Drinker-vs-Weekly Drinker
2.687800E-01
Non Drinker-vs-Occasional Drinker
3.898600E-01
Non Drinker-vs-Social Drinker
2.152000E-01
Daily Drinker-vs-Weekly Drinker
1.213780E-02
Daily Drinker-vs-Occasional Drinker
4.978300E-03
Daily Drinker-vs-Social Drinker
1.082450E-02
Weekly Drinker-vs-Occasional Drinker
6.637000E-01
Weekly Drinker-vs-Social Drinker
8.974600E-01
Occasional Drinker-vs-Social Drinker
5.719600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.188400E-01
Normal-vs-Grade 2
5.915700E-02
Normal-vs-Grade 3
1.172790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.516000E-01
Grade 1-vs-Grade 3
8.851600E-01
Grade 1-vs-Grade 4
2.188400E-01
Grade 2-vs-Grade 3
4.735600E-01
Grade 2-vs-Grade 4
5.915700E-02
Grade 3-vs-Grade 4
1.172790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.198600E-01
Normal-vs-NonDiabetic
4.030200E-01
Diabetic-vs-NonDiabetic
9.527800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.929400E-01
Normal-vs-NoPancreatitis
4.862000E-01
Pancreatitis-vs-NoPancreatitis
5.345700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.988800E-01
Normal-vs-N1
3.926200E-01
N0-vs-N1
1.790420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.146200E-01
Normal-vs-TP53-NonMutant
8.771600E-01
TP53-Mutant-vs-TP53-NonMutant
3.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
